Neurology
-
To determine dosing and side effects of dihydroergotamine as they affect outcomes in primary headache disorders. ⋯ Intravenous dihydroergotamine is well-tolerated, and longer treatments produce a better outcome. Nausea is the most common adverse effect, and its control is associated with a better outcome.